Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal

Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age16-75
SponsorThe First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

About this trial

The investigators designed this clinical study to evaluate the efficacy and safety of semi-standardized acupuncture and moxibustion combined with compound diclofenac sodium injection in the emergency department (ED) compared with acupuncture or compound diclofenac sodium injection alone.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The diagnostic criteria of NTAA were as follows: ① abdominal pain was the main symptom; ② The onset time was less than 1 week; ③ The cause of abdominal pain could be traced to intra-abdominal abdominal wall chest or systemic diseases;

Patients with NRS scores ≥4 (mild pain and above) were evaluated before inclusion; (3)16 years < age <75 years;

Disqualifiers

Acute abdomen caused by trauma;

Super sudden diseases (e.g. acute myocardial infarction rupture of abdominal aortic aneurysm pulmonary embolism aortic dissection pericardial tamponade);

Emergent conditions requiring surgical treatment within 3 hours (e.g. rupture of liver cancer ectopic pregnancy ischemic bowel disease severe acute cholangitis peritonitis with septic shock);

Extremely severe pain (NRS ≥ 8) with an undetermined diagnosis and requiring further assessment for a super sudden disease;

Trial design

Design model

Parallel

Treatments tested in this trial

  • acupuncture

    Procedure/Surgery

    acupuncture at Zusanli (ST36); sample size: 44

  • compound diclofenac sodium

    Drug

    intramuscular injection of compound diclofenac sodium injection; sample size: 44

  • acupuncture combined with compound diclofenac sodium

    Combination product

    acupuncture at Zusanli (ST36) and intramuscular injection of compound diclofenac sodium injection; sample size: 44

  • placebo

    Combination product

    superficial acupuncture at Zusanli (ST36) and intramuscular injection of normal saline; sample size: 44

Treatment groups

176 Participants
are divided into 4 treatment groups
Group A: acupuncture groupActive comparator 4 interventions
Group B: compound diclofenac sodium groupActive comparator 4 interventions
Group C: acupuncture combined with compound diclofenac sodium groupExperimental treatment 4 interventions
Group D: placebo groupPlacebo comparator 4 interventions

Trial outcomes

Primary outcomes

1

Pain response rate

Using the Numeric Rating Scale (NRS) score evaluate the proportion of individuals within the group who achieved a therapeutic index of ≥50% at the 10th minute post-treatment compared to baseline

Time frame
at 10 minutes after analgesia

Secondary outcomes

1

The utilization rate of rescue drugs

If the subject still experiences intolerable pain (NRS ≥ 4) after 1 hour of treatment or following supplemental treatment, additional analgesic medications such as Rotundine or Dezocine shall be administered. Furthermore, subjects who still exhibit "severe pain" after 1 hour of treatment will be given rescue analgesic medication: Pethidine Hydrochloride Injection, 25 mg, intramuscularly (to be prescribed by a supervising physician with the qualifications to prescribe narcotic drugs).

Time frame
within 1 hour to 1 day post-analgesia
2

Expectations with the intervention

In this study, a Likert scale was utilized to construct a specialized questionnaire aimed at assessing patients' expectations of the intervention. The questionnaire consists of four items designed to evaluate patients' anticipations regarding the intervention's efficacy in alleviating symptoms, its onset of action, potential side effects, and its impact on quality of life. Each item is scored on a five-point scale, ranging from 1 (strongly disagree) to 5 (strongly agree). At baseline, the ratings for each item were determined according to the personal expectations of the patients. To provide a comprehensive reflection of patients' overall expectations of the intervention, each item is assigned equal weight in the total score calculation. The scores of the four items are summed to yield a total score, which quantifies patients' overall expectations of the intervention.

Time frame
baseline
3

Satisfaction with the intervention

In this study, a Likert scale was employed to develop a specialized questionnaire designed to assess patient satisfaction with the intervention. The questionnaire comprehensively evaluates patient satisfaction across multiple dimensions, including satisfaction with the treatment process, experience of side effects, and overall satisfaction. Each dimension is rated on a five-point scale, ranging from 1 (strongly disagree) to 5 (strongly agree). The items in the questionnaire were rated by patients based on their actual experiences on the first day after the intervention. To provide a comprehensive reflection of patients' overall satisfaction with the intervention, each item carries equal weight in the total score calculation. The scores of all items are summed to yield a total score, which quantifies the patients' overall satisfaction with the intervention.

Time frame
at 1 day after analgesia
4

Numeric Rating Scale (NRS) score

Numeric Rating Scale

Time frame
at 0, 1, 5, 10, 20, 30, and 60 minutes, and at 1 and 3 days post-analgesia

Other outcomes

1

Avatar Incidence of adverse events

During the entire treatment period and follow-up period: Adverse events were evaluated immediately after the intervention, at 0, 1, 5, 10, 20, 30, and 60 minutes after the treatment, and during the follow-up periods on the first and third days after the intervention. The frequency of adverse events in each group was recorded, and the proportion of adverse events was calculated.

Time frame
through study completion, an average of 3 days

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: